Date & Location: Saturday, May 17, 2025, 7:45 AM – 3:10 PM, Smilow Center, Rubenstein Auditorium, Philadelphia, PA
The annual Penn Neuromuscular Symposium will discuss available and novel therapies for patients with neuromuscular disorders ranging from immuno-modulation to gene therapy. Experts will also present clinical cases selected from the Penn neuromuscular clinic to discuss where new diagnostic methods and treatments apply. The course will be interactive and attendees are encouraged to participate and exchange their experience and ask questions as they see fit. The Symposium will also explain how to enhance collaboration and knowledge exchange among neurologists and other healthcare professionals taking care of this unique patient population, which will also help facilitate enrollment in exciting clinical trials.
Target Audience
Specialties – NEUROLOGICAL SURGERY, NEUROLOGY, NEUROLOGY WITH SPECIAL QUALIFICATION IN CHILD NEUROLOGY, PSYCHIATRY AND NEUROLOGY – Addiction Psychiatry, PSYCHIATRY AND NEUROLOGY – Brain Injury Medicine, PSYCHIATRY AND NEUROLOGY – Child and Adolescent Psychiatry, PSYCHIATRY AND NEUROLOGY – Clinical Neurophysiology, PSYCHIATRY AND NEUROLOGY – Consultation-Liaison Psychiatry, PSYCHIATRY AND NEUROLOGY – Epilepsy, PSYCHIATRY AND NEUROLOGY – Forensic Psychiatry, PSYCHIATRY AND NEUROLOGY – Geriatric Psychiatry, PSYCHIATRY AND NEUROLOGY – Hospice and Palliative Medicine, PSYCHIATRY AND NEUROLOGY – Neurodevelopmental Disabilities, PSYCHIATRY AND NEUROLOGY – Neuromuscular Medicine, PSYCHIATRY AND NEUROLOGY – Pain Medicine, PSYCHIATRY AND NEUROLOGY – Sleep Medicine, PSYCHIATRY AND NEUROLOGY – Vascular Neurology
Professions – Nurse Practitioners, Physicians
Learning Objectives
After completing this activity, participants should be able to:
Describe novel treatment in myasthenia gravis
Discuss new methods to diagnose and treat neuropathy in Hereditary Transthyretin Amyloidosis.
Discuss different type of demyelinating neuropathies and how to manage them
Describe novel treatments for people with SMA and ALS
Discuss management of neuromuscular complications of vasculitis
Apply antibody testing in inflammatory myopathies and describe novel therapies for inflammatory myopathies
Discuss gene therapy for hereditary myopathies
Discuss application of car-T in autoimmune neuromuscular disorders
The Penn Neuromuscular Symposium 2025 is best for neurologists, physiatrists, and allied health professionals managing patients with neuromuscular disorders. It’s ideal for:
Exploring novel therapies including immunomodulation and gene therapy
Reviewing real-world clinical cases from Penn’s neuromuscular clinic
Engaging in interactive discussions on diagnostics and treatment strategies
Date: May 17, 2025 Time: 7:45 AM – 3:10 PM (ET) Location: Smilow Center for Translational Research, Philadelphia, PA
+ Topics:
Saturday, May 17, 2025
8:20AM – 8:30AM Welcome Chafic Karam, MD
MORNING SESSION
8:30AM – 9:00AM Update on SMA and ALS Treatments Lauren Elman, MD
9:00AM – 9:30AM Novel Therapies in CIDP, GBS and MMN Rami Massie, MD
9:30AM – 9:50AM Case Presentations Rebecca Hsu, MD
9:50AM – 10:10AM Break
10:10AM – 10:50AM Updates in Myasthenia Gravis Bird Shawn, MD
10:50AM – 11:10AM Serum Neurofilament Light Chain in Patients with Peripheral Neuropathy Chafic Karam, MD
11:10AM – 11:30AM Updates in Diagnosis and Management of Hereditary Transthyretin Amyloidosis Michelle Kaku, MD
11:30AM – 11:50AM Case Presentations Michael Baer, MD
11:50AM – 12:50PM Lunch Break
AFTERNOON SESSION
12:50PM – 1:20PM ARTHUR ASBURY ENDOWMENT LECTURE: A. Gordon Smith, MD
1:20PM – 1:40PM Case Presentations Paul T Mcintosh, MD
1:40PM – 2:10PM Update in Treatment of Hereditary Myopathies Colin Quinn, MD
2:10PM – 2:20PM Break
2:20PM – 2:40PM Updates in the Management of Vasculitis Naomi Amudala, CRNP RN
2:40PM – 3:00PM Car-T in Auto-immune Disorders Nasheed Hossain, MD
3:00PM – 3:10PM Questions & Wrap Up





Reviews
There are no reviews yet.